Option Care Health, Inc. (NASDAQ:OPCH) Q2 2024 Earnings Conference Call July 31, 2024 8:30 AM ET

Company Participants

Nicole Maggio - Senior Vice President of Finance
John Rademacher - President & CEO
Mike Shapiro - CFO

Conference Call Participants

Lisa Gill - JPMorgan
Constantine Davides - Citizens JMP
Matt Larew - William Blair
David MacDonald - Truist Securities
Pito Chickering - Deutsche Bank
Brian Tanquilut - Jefferies
Joanna Gajuk - Bank of America
Michael Petusky - Barrington Research

Operator

Good day, and thank you for standing by. Welcome to the Option Care Health Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Nicole Maggio, Senior Vice President of Finance. Please go ahead.

Nicole Maggio

Good morning. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance and industry and market conditions. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our expectations. We encourage you to review the information in today's press release as well as in our Form 10-K and latest Form 10-Q filed with the SEC regarding the specific risks and uncertainties.

We do not undertake any duty to update any forward-looking statements, except as required by law. During this call, we will use non-GAAP financial measures when talking about the company's performance and financial condition. You can find additional information on these non-GAAP measures in this morning's press release posted on the Investor Relations portion of our website.

With that, I'll turn the call over to John Rademacher, Chief Executive Officer.

John Rademacher

Thanks, Nicole and good morning, everyone. The second quarter was another productive quarter for the Option Care Health team despite a number of challenging dynamics. On our last call, we were in the midst of one of the most disruptive cyberattacks on the healthcare ecosystem in history and managing through a number of supply chain disruptions that were putting pressure on our business.

As we sit here today, I'm pleased to report that the team has made significant progress in managing through and recovering from these challenges. Building upon the momentum exiting the first quarter, the top line continues to perform well as the team delivered year-over-year growth of 14.8%. Growth was balanced across the portfolio and consistent with the first quarter, we saw especially robust growth from our newer limited distribution and rare orphan therapies within our chronic portfolio.